title: PET and SPECT in brain tumors and epilepsy.
abstract: Molecular imaging with positron emission tomography (PET) plays an important role in the diagnosis and management of patients with brain tumors and epilepsy. The clinical uses of FDG are discussed, as well as the research applications of novel PET tracers. Where applicable, single-photon emission computed tomography (SPECT) is also discussed.
authors: Division of Nuclear Medicine and Molecular Imaging, Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, 75 Francis Street, Boston, MA 02115, USA. lhorky@partners.org
authors: Laura L
authors: LL
authors: Horky
authors: S Ted
authors: ST
authors: Treves
mesh_terms: D001921:Brain / Q000000981:diagnostic imaging*; D001932:Brain Neoplasms / Q000000981:diagnostic imaging*; D049109:Cell Proliferation; D015224:Dideoxynucleosides; D004827:Epilepsy / Q000000981:diagnostic imaging*; D005442:Flumazenil; D019788:Fluorodeoxyglucose F18; D018757:GABA Modulators; D006801:Humans; D009336:Necrosis; D009364:Neoplasm Recurrence, Local; D049268:Positron-Emission Tomography / Q000379:methods*; D019275:Radiopharmaceuticals; D015899:Tomography, Emission-Computed, Single-Photon / Q000379:methods*
chemical_list: D015224:Dideoxynucleosides; D018757:GABA Modulators; D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18; D005442:Flumazenil; C002854:alovudine